Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000248083 | SCV000307401 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
EGL Genetic Diagnostics, |
RCV000725702 | SCV000338739 | uncertain significance | not provided | 2016-01-05 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000248083 | SCV000523700 | likely benign | not specified | 2017-08-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV001080324 | SCV000640888 | likely benign | Nemaline myopathy 2 | 2019-12-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001080324 | SCV001454968 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |